Tofersen and the Future of ALS Drug Development
58:05
Antisense Oligonucleotide Therapy for ALS
27:23
FDA Advisory Committee to Consider Tofersen
15:22
Can we stop MS and ALS? | Michael C. Levin | TEDxUniversityofSaskatchewan
9:31
The Drug Development Process in Pharma
1:31:31
How to Slow ALS Progression
19:09
FDA Approved Therapy for SOD1 Associated ALS
52:07
2024 HHS: Clinical Trials in Florida
19:03